Literature DB >> 2605067

Timing of treatment with oxygen radical scavengers and its influence on reperfusion injury.

G Ambrosio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2605067      PMCID： PMC1216798          DOI： 10.1136/hrt.62.6.490-b

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  9 in total

1.  Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.

Authors:  G Ambrosio; J L Zweier; W E Jacobus; M L Weisfeldt; J T Flaherty
Journal:  Circulation       Date:  1987-10       Impact factor: 29.690

2.  "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.

Authors:  K Przyklenk; R A Kloner
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

3.  Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs.

Authors:  J Nejima; D R Knight; J T Fallon; N Uemura; W T Manders; D R Canfield; M V Cohen; S F Vatner
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

4.  Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone.

Authors:  R Bolli; B S Patel; M O Jeroudi; E K Lai; P B McCay
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.

Authors:  G Ambrosio; M L Weisfeldt; W E Jacobus; J T Flaherty
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

6.  Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

Authors:  S R Jolly; W J Kane; M B Bailie; G D Abrams; B R Lucchesi
Journal:  Circ Res       Date:  1984-03       Impact factor: 17.367

7.  Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium.

Authors:  J L Zweier; B K Rayburn; J T Flaherty; M L Weisfeldt
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.

Authors:  G Ambrosio; L C Becker; G M Hutchins; H F Weisman; M L Weisfeldt
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

9.  Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs.

Authors:  V J Richard; C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.